Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.32 by 3.13 percent. This is a 29.79 percent decrease over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $478.71 million which beat the analyst consensus estimate of $462.37 million by 3.53 percent. This is a 37.49 percent increase over sales of $348.17 million the same period last year.